Chapter 4, "Regulating pharamaceutical drugs - Health Canada", of the Fall 2011 report of the Auditor General of Canada [electronic resource] : report of the Standing Committee on Public Accounts / David Christopherson, chair

Corporate Author:: Canada. Parliament. House of Commons. Standing Committee on Public Accounts
Additional Titles:: Report of the Standing Committee on Public Accounts
Published:: [Ottawa] : Standing Committee on Public Accounts, 2013.
Edition:: [Corr. ed.].
Additional Creators:: Christopherson, Dave

Access Online

epe.lac , Free-to-read: For holdings see LAC's Electronic Collection.
publications.gc.ca , Free-to-read

Availability

Finding items...

Restrictions on Access:

Free-to-read Unrestricted online access

Report Numbers:

XC16-1/1-411-11E-PDF

Subject(s):

Canada. Health Canada
Canada. Santé Canada
Drugs—Safety regulations—Canada
Drugs—Testing—Government policy—Canada
Drug approval—Canada
Pharmaceutical policy—Canada
Drugs—Law and legislation—Canada
Médicaments—Sécurité—Règlements—Canada
Médicaments—Essais cliniques—Politique gouvernementale—Canada
Médicaments—Autorisation de mise sur le marché—Canada
Médicaments—Politique gouvernementale—Canada
Médicaments—Droit—Canada

Note:

Issued also in French under title: Chapitre 4, "La réglementation des médicaments - Santé Canada", du rapport d'automne 2011 du vérificateur général du Canada.
Distributed by the Government of Canada Depository Services Program (Weekly checklist 2013-08).
"February 2013".
"41st parliament, 1st Session".

Bibliography Note:

Includes bibliographical references.

Type of File/Data:

Electronic monograph in PDF format.

Other Forms:

Issued also in printed form.

View MARC record | catkey: 25071583